Get started
Work

Artificial Pancreas Goes Outpatient: A New Diabetes Ecosystem

Year: 2013
Type: editorial
Abstract: The artificial pancreas (AP) offers an ideal solution to many patients with diabetes treated by insulin because it covers the triple aim of diabetes therapy: (i) close-to-normal mean glucose control in order to prevent long-term diabetes complications, (ii) maintenance of glucose levels in a safe range in order to avoid acute brain-debilitating glucose excursions, and (iii) minimal burden in disease management thanks to a discrete wearable system, including an insulin infuser, a glucose monitor, and a diabetes controller.
DOI: 10.1177/193229681300700601
Institutions: Inserm, Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Institut de Génomique Fonctionnelle, University of Padua, University of California, Santa Barbara, Sansum Diabetes Research Institute, University of Virginia
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2115417281
Cites: 9
Cited by: 15
Related to: 10